HIGH SUSANNA GATTI has filed 41 insider transactions across 1 company since March 2023.
Most recent transaction: a sale of 4340 shares of Dyne Therapeutics, Inc. ($DYN) on September 18, 2024.
Activity breakdown: 0 open-market purchases and 27 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 18, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 4340 | $34.41 | 136,272.0000 | 0 | 3.09% | 0.00% |
| Sept. 18, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 4636 | $34.41 | 131,636.0000 | 0 | 3.40% | 0.00% |
| Sept. 11, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2548 | $31.89 | 143,334.0000 | 0 | 1.75% | 0.00% |
| Sept. 11, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2722 | $31.89 | 140,612.0000 | 0 | 1.90% | 0.00% |
| Aug. 19, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2582 | $45.01 | 146,210.0000 | 0 | 1.74% | 0.00% |
| Aug. 19, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 328 | $46.00 | 145,882.0000 | 0 | 0.22% | 0.00% |
| June 21, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 29787 | $35.01 | 148,792.0000 | 0 | 16.68% | 0.00% |
| June 24, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 10213 | $0.00 | 60,486.0000 | 0 | 14.45% | 0.00% |
| June 21, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 29787 | $0.00 | 70,699.0000 | 0 | 29.64% | 0.00% |
| June 24, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 10213 | $35.33 | 148,792.0000 | 0 | 6.42% | 0.00% |
| June 24, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 10213 | $5.54 | 159,005.0000 | 0 | 6.86% | 0.00% |
| June 21, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 29787 | $5.54 | 178,579.0000 | 0 | 20.02% | 0.00% |
| June 24, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 10163 | $0.00 | 60,536.0000 | 0 | 14.38% | 0.00% |
| June 21, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 29787 | $5.54 | 178,579.0000 | 0 | 20.02% | 0.00% |
| June 21, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 29787 | $35.01 | 148,792.0000 | 0 | 16.68% | 0.00% |
| June 24, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 10163 | $5.54 | 158,955.0000 | 0 | 6.83% | 0.00% |
| June 24, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 10163 | $35.33 | 148,792.0000 | 0 | 6.39% | 0.00% |
| June 21, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 29787 | $0.00 | 70,699.0000 | 0 | 29.64% | 0.00% |
| June 12, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 40000 | $0.00 | 100,486.0000 | 0 | 28.47% | 0.00% |
| June 12, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 13964 | $33.70 | 148,792.0000 | 0 | 8.58% | 0.00% |
| June 12, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 40000 | $5.54 | 188,792.0000 | 0 | 26.88% | 0.00% |
| June 12, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 26036 | $33.17 | 162,756.0000 | 0 | 13.79% | 0.00% |
| June 10, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Common Stock | 80000 | $5.54 | 234,062.0000 | 0 | 51.93% | 0.00% |
| June 10, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 80000 | $30.24 | 154,062.0000 | 0 | 34.18% | 0.00% |
| June 10, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | M | Stock option (right to buy) | 80000 | $0.00 | 140,486.0000 | 0 | 36.28% | 0.00% |
| June 11, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2913 | $31.23 | 148,792.0000 | 0 | 1.92% | 0.00% |
| June 11, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2357 | $31.23 | 151,705.0000 | 0 | 1.53% | 0.00% |
| May 16, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 489 | $28.59 | 154,062.0000 | 0 | 0.32% | 0.00% |
| May 16, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2249 | $28.20 | 154,551.0000 | 0 | 1.43% | 0.00% |
| March 8, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 26908 | $26.66 | 159,383.0000 | 0 | 14.44% | 0.00% |
| March 11, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2292 | $25.70 | 156,800.0000 | 0 | 1.44% | 0.00% |
| March 8, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 291 | $27.41 | 159,092.0000 | 0 | 0.18% | 0.00% |
| March 7, 2024 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1591 | $25.85 | 186,291.0000 | 0 | 0.85% | 0.00% |
| Dec. 11, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1616 | $10.72 | 187,882.0000 | 0 | 0.85% | 0.00% |
| Nov. 15, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | A | Stock Option (right to buy) | 36952 | $0.00 | 36,952.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | A | Common Stock | 94893 | $0.00 | 189,498.0000 | 0 | 100.30% | 0.00% |
| Nov. 2, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 9939 | $7.40 | 94,605.0000 | 0 | 9.51% | 0.00% |
| Sept. 18, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 2672 | $9.41 | 104,544.0000 | 0 | 2.49% | 0.00% |
| Sept. 12, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1635 | $10.41 | 107,216.0000 | 0 | 1.50% | 0.00% |
| June 13, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1625 | $12.43 | 108,851.0000 | 0 | 1.47% | 0.00% |
| March 14, 2023 | Dyne Therapeutics, Inc. | $DYN | HIGH SUSANNA GATTI | Chief Operating Officer | S | Common Stock | 1559 | $13.33 | 110,476.0000 | 0 | 1.39% | 0.00% |